Spatially Weighted Coronary Artery Calcium Score and Coronary Heart Disease Events in the Multi-Ethnic Study of Atherosclerosis
- PMID: 33461306
- PMCID: PMC7987729
- DOI: 10.1161/CIRCIMAGING.120.011981
Spatially Weighted Coronary Artery Calcium Score and Coronary Heart Disease Events in the Multi-Ethnic Study of Atherosclerosis
Abstract
Background: A limitation of the Agatston coronary artery calcium (CAC) score is that it does not use all of the calcium density information in the computed tomography scan such that many individuals have a score of zero. We examined the predictive validity for incident coronary heart disease (CHD) events of the spatially weighted coronary calcium score (SWCS), an alternative scoring method for CAC that assigns scores to individuals with Agatston CAC=0.
Methods: The MESA (Multi-Ethnic Study of Atherosclerosis) is a longitudinal study that conducted a baseline exam from 2000 to 2002 in 6814 participants including computed tomography scanning for CAC. Subsequent exams and systematic follow-up of the cohort for outcomes were performed. Statistical models were adjusted using the MESA risk score based on age, sex, race/ethnicity, systolic blood pressure, use of hypertension medications, diabetes, total and HDL (high-density lipoprotein) cholesterol, use of lipid-lowering medications, smoking status, and family history of heart attack.
Results: In the 3286 participants with Agatston CAC=0 at baseline and for whom SWCS was computed, 98 incident CHD events defined as definite or probably myocardial infarction or definite CHD death occurred during a median follow-up of 15.1 years. In this group, SWCS predicted incident CHD events after multivariable adjustment (hazard ratio=1.30 per SD of natural logarithm [SWCS] [95% CI, 1.04-1.60]; P=0.005); and progression from Agatston CAC=0 at baseline to CAC>0 at subsequent exams (multivariable-adjusted incidence rate difference per SD of natural logarithm [SWCS] per 100 person-years 1.68 [95% CI, 1.03-2.33]; P<0.0001).
Conclusions: SWCS predicts incident CHD events in individuals with Agatston CAC score=0 as well as conversion to Agatston CAC>0 at repeat computed tomography scanning at later exams. SWCS has predictive validity as a subclinical phenotype and marker of CHD risk in individuals with Agatston CAC=0.
Keywords: atherosclerosis; blood pressure; calcium; heart diseases; hypertension.
Figures
Comment in
-
Spatially Weighted Calcium Score Beyond Power of Zero: Worth the Effort?Circ Cardiovasc Imaging. 2021 Jan;14(1):e012236. doi: 10.1161/CIRCIMAGING.120.012236. Epub 2021 Jan 19. Circ Cardiovasc Imaging. 2021. PMID: 33463364 No abstract available.
Similar articles
-
Association of Coronary Artery Calcium in Adults Aged 32 to 46 Years With Incident Coronary Heart Disease and Death.JAMA Cardiol. 2017 Apr 1;2(4):391-399. doi: 10.1001/jamacardio.2016.5493. JAMA Cardiol. 2017. PMID: 28196265 Free PMC article.
-
Derivation of a Coronary Age Calculator Using Traditional Risk Factors and Coronary Artery Calcium: The Multi-Ethnic Study of Atherosclerosis.J Am Heart Assoc. 2021 Mar 16;10(6):e019351. doi: 10.1161/JAHA.120.019351. Epub 2021 Mar 5. J Am Heart Assoc. 2021. PMID: 33663219 Free PMC article.
-
Greater Volume but not Higher Density of Abdominal Aortic Calcium Is Associated With Increased Cardiovascular Disease Risk: MESA (Multi-Ethnic Study of Atherosclerosis).Circ Cardiovasc Imaging. 2016 Nov;9(11):e005138. doi: 10.1161/CIRCIMAGING.116.005138. Circ Cardiovasc Imaging. 2016. PMID: 27903540 Free PMC article.
-
Association of polygenic risk scores with incident atherosclerotic cardiovascular disease events among individuals with coronary artery calcium score of zero: The multi-ethnic study of atherosclerosis.Prog Cardiovasc Dis. 2022 Sep-Oct;74:19-27. doi: 10.1016/j.pcad.2022.08.003. Epub 2022 Aug 8. Prog Cardiovasc Dis. 2022. PMID: 35952728 Free PMC article. Review.
-
Is there a role for coronary artery calcium scoring for management of asymptomatic patients at risk for coronary artery disease?: Clinical risk scores are sufficient to define primary prevention treatment strategies among asymptomatic patients.Circ Cardiovasc Imaging. 2014 Mar;7(2):390-7; discussion 397. doi: 10.1161/CIRCIMAGING.113.000470. Circ Cardiovasc Imaging. 2014. PMID: 24642921 Free PMC article. Review. No abstract available.
Cited by
-
Association between triglyceride glucose index and arterial stiffness and coronary artery calcification: a systematic review and exposure-effect meta-analysis.Cardiovasc Diabetol. 2023 May 13;22(1):111. doi: 10.1186/s12933-023-01819-2. Cardiovasc Diabetol. 2023. PMID: 37179288 Free PMC article.
-
3D printed phantom with 12 000 submillimeter lesions to improve efficiency in CT detectability assessment.Med Phys. 2024 May;51(5):3265-3274. doi: 10.1002/mp.17064. Epub 2024 Apr 8. Med Phys. 2024. PMID: 38588491 Free PMC article.
-
Immune-related potential biomarkers and therapeutic targets in coronary artery disease.Front Cardiovasc Med. 2023 Jan 6;9:1055422. doi: 10.3389/fcvm.2022.1055422. eCollection 2022. Front Cardiovasc Med. 2023. PMID: 36684561 Free PMC article.
-
Natural phytochemicals prevent side effects in BRCA-mutated ovarian cancer and PARP inhibitor treatment.Front Pharmacol. 2022 Dec 7;13:1078303. doi: 10.3389/fphar.2022.1078303. eCollection 2022. Front Pharmacol. 2022. PMID: 36569329 Free PMC article. Review.
-
Associations Between Visceral Fat, Abdominal Muscle, and Coronary Artery Calcification: A Cross-Sectional Analysis of the Multi-Ethnic Study of Atherosclerosis.Am J Cardiol. 2024 Apr 15;217:77-85. doi: 10.1016/j.amjcard.2024.02.030. Epub 2024 Mar 1. Am J Cardiol. 2024. PMID: 38432335 Free PMC article.
References
-
- Ross R Atherosclerosis—an inflammatory disease. New Engl J Med 1999;340:115–26. - PubMed
-
- Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. New Engl J Med 2005;352:1685–95. - PubMed
-
- Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135–43. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01 HC095168/HL/NHLBI NIH HHS/United States
- 75N92020D00001/HL/NHLBI NIH HHS/United States
- N01 HC095161/HC/NHLBI NIH HHS/United States
- N01 HC095167/HL/NHLBI NIH HHS/United States
- P42 ES010349/ES/NIEHS NIH HHS/United States
- HHSN268201500003I/HL/NHLBI NIH HHS/United States
- UL1 TR000040/TR/NCATS NIH HHS/United States
- N01 HC095166/HL/NHLBI NIH HHS/United States
- 75N92020D00002/HL/NHLBI NIH HHS/United States
- HHSN268201500003C/HL/NHLBI NIH HHS/United States
- N01 HC095161/HL/NHLBI NIH HHS/United States
- 75N92020D00005/HL/NHLBI NIH HHS/United States
- UL1 TR001079/TR/NCATS NIH HHS/United States
- N01 HC095169/HL/NHLBI NIH HHS/United States
- R01 ES028758/ES/NIEHS NIH HHS/United States
- R01 HL134149/HL/NHLBI NIH HHS/United States
- KL2 TR001874/TR/NCATS NIH HHS/United States
- N01 HC095159/HL/NHLBI NIH HHS/United States
- 75N92020D00003/HL/NHLBI NIH HHS/United States
- UL1 TR001420/TR/NCATS NIH HHS/United States
- 75N92020D00004/HL/NHLBI NIH HHS/United States
- N01 HC095163/HL/NHLBI NIH HHS/United States
- 75N92020D00007/HL/NHLBI NIH HHS/United States
- N01 HC095162/HL/NHLBI NIH HHS/United States
- 75N92020D00006/HL/NHLBI NIH HHS/United States
- R01 ES029967/ES/NIEHS NIH HHS/United States
- N01 HC095165/HL/NHLBI NIH HHS/United States
- N01 HC095164/HL/NHLBI NIH HHS/United States
- P30 ES009089/ES/NIEHS NIH HHS/United States
- N01 HC095160/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical